Table 4. Number and activity of neurocysticercosis lesions on cerebral computed tomography scan and cysticercosis antibody results.

Number of NCC	EITB CDC		Commercial Western Blot		CSF both tests
lesions on CT scan*	Negative	Positive	Negative	Positive	Negative	Positive
0	42 (91.3%)	4 (8.7%)	20 (100%)	0 (0.0%)	0	0
1	7 (77.8%)	2 (22.2%)	0	0	0	0
2–4	5 (45.5%)	6 (54.5%)	6 (100%)	0 (0.0%)	3 (100%)	0 (0.0%)
≥5	4 (26.7%)	11 (73.3%)	8 (57.1%)	6 (42.9%)	3 (37.5%)	5 (62.5%)
Total	58 (71.6%)	23 (28.4%)	34 (85.0%)	6 (15.0%)	6 (54.5%)	5 (45.5%)
Activity of NCC lesions on CT scan
Inactive	16 (55.2%)	13 (44.8%)	13 (92.9%)	1 (7.1%)	6 (85.7%)	1 (14.3%)
Active	0 (0%)	6 (100%)	1 (16.7%)	5 (83.3%)	0 (0%)	4 (100%)

*Including active and inactive lesions; NCC... Neurocysticercosis, CDC EITB... Electroimmunotransfer blot developed by the Centers for Disease Control and Prevention, in Atlanta, GA, USA, CSF... Cerebrospinal fluid, CT...Computed tomography.